← FDA DRUG APPROVALS

FDA ANDA · ANDA077827

OXANDROLONE

Sponsor: PAR PHARM

APPLICATION
ANDA077827
TYPE
ANDA
ORIGINAL APPROVAL
2007-06-22
LATEST ACTION
2007-12-31
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

OXANDROLONEDiscontinued
OXANDROLONE 10MG · TABLET · ORAL
OXANDROLONEDiscontinued
OXANDROLONE 2.5MG · TABLET · ORAL

Approval history

2007-12-31Labeling · Supplement 1 — Letter ↗AP
2007-06-22OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →